Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

Clinical trial NCT04516395 · UNKNOWN

Trial details

NCT number: NCT04516395
Sponsor: Phramongkutklao College of Medicine and Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Drug Resistance Carbapenem-Resistant Enterobacteriaceae Infection Sepsis Septic Shock Critical Illness Clinical Outcomes Treatment Outcomes

Start date: 2020-09-01
Primary completion: 2021-03-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.